Exploring the self-efficacy and self-care-based stroke care model for risk factor modification in mild-to-moderate stroke patients

ContextThe worldwide burden of stroke is projected to grow unless proper stroke education is implemented. Information alone cannot promote patient self-efficacy and self-care and reduce risk factors.AimThis trial aimed to test self-efficacy and self-care-based stroke education (SSE) on changes in se...

Full description

Bibliographic Details
Main Authors: Al Rasyid, Uke Pemila, Siti Aisah, Salim Harris, Elvan Wiyarta, Marc Fisher
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1177083/full
Description
Summary:ContextThe worldwide burden of stroke is projected to grow unless proper stroke education is implemented. Information alone cannot promote patient self-efficacy and self-care and reduce risk factors.AimThis trial aimed to test self-efficacy and self-care-based stroke education (SSE) on changes in self-efficacy, self-care, and risk factor modification.Design, setting, and participantsThis study is a single-center, double-blinded, interventional, two-arm randomized controlled trial with a 1- and 3-month follow-up in Indonesia. Between January 2022 and October 2022, 120 patients were prospectively enrolled from Cipto Mangunkusumo National Hospital, Indonesia. Participants were assigned using a computer-generated random number list.InterventionSSE was given before discharge from the hospital.Primary outcome measureSelf-care, self-efficacy, and stroke risk score was measured 1 month and 3 months after discharge.Secondary outcome measureModified Rankin Scale, Barthel Index, and blood viscosity was measured at 1 month and 3 months after discharge.ResultsA total of 120 patients (intervention n = 60; standard care n = 60) were randomized. In the 1st month, the intervention group showed a more significant change in self-care (4.56 [95% CI: 0.57, 8.56]), self-efficacy (4.95 [95% CI: 0.84, 9.06]), and stroke risk (−2.33 [95% CI:−3.19, −1.47]) compared to the controlled group. In the 3rd month, the intervention group also showed a more significant change in self-care (19.28 [95% CI: 16.01, 22.56]), self-efficacy (19.95 [95% CI: 16.61, 23.28]), and stroke risk (−3.83 [95% CI: −4.65, −3.01]) compared to the controlled group.ConclusionSSE may boost self-care and self-efficacy, adjust risk factors, enhance functional outcomes, and decrease blood viscosity.Clinical trial registrationISRCTN11495822.
ISSN:1664-2295